Molecular Medicine (journal)
 | ''Mol Med'' doesn't exist. |
| Discipline | Pre-clinical medicine |
|---|---|
| Language | English |
| Edited by | Kevin J. Tracey, Anthony Cerami |
| Publication details | |
| History | founded 1994 |
| Publisher | Feinstein Institute for Medical Research (U.S.A) |
| Frequency | 6 per year |
| immediate | |
| 2.708 (2007) | |
| Standard abbreviations | |
| ISO 4 | 'Mol Med' |
| Indexing | |
| ISSN | 1076-1551 (print) 1528-3658 (web) |
| Links | |
Molecular Medicine is a peer-reviewed biomedical journal published by the Feinstein Institute for Medical Research (also known as the North Shore Long Island Jewish Research Institute) from offices in Manhasset, New York, USA. Founded in 1994,[1] it appears six times a year.
Molecular Medicine is a multi-disciplinary journal which focuses on understanding the pathogenesis of disease at the molecular level and translating this knowledge into specific molecular tools for diagnosis, treatment and prevention.
As of 2008, the journal's Editors-in-Chief are Kevin J. Tracey (Feinstein Institute for Medical Research, USA) and Anthony Cerami (Kenneth S. Warren Laboratories, USA). Molecular Medicine is indexed by Medline. The impact factor for 2007 is 2.708.[2]
Open, full-text access to all publications dating back to 2000 is available via the journal's website. A biweekly podcast "Mollie Medcast", was launched in 2007; it includes brief audio summaries of recent articles. Other features include an online Molecular Medicine Frappr Map and an RSS feed. A forthcoming compendium lecture series, "The Centricity Series", to cover recent biomedical research on complex diseases such as sepsis, cancer, Alzheimer’s, arthritis and lupus was announced in January 2008.[3]
References
- ^ NLM: Molecular medicine (Cambridge, Mass.) (accessed 31 January 2008)
- ^ About Molecular Medicine (accessed 31 January 2008)
- ^ Gallowitsch-Puerta M. (2008) Editorial. Mol Med 14: 1